Total Value
$1005.88B
Holdings Count
17
Period of Report
Dec 31, 2024
Report Type
HR
| Issuer | CUSIP | Value | Shares |
|---|---|---|---|
| AXSOME THERAPEUTICS INC | 05464T104 | $124.29B | 1,468,983 |
| NUVALENT INC | 670703107 | $103.15B | 1,317,664 |
| SPYRE THERAPEUTICS INC | 00773J202 | $93.54B | 4,018,101 |
| APOGEE THERAPEUTICS INC | 03770N101 | $92.80B | 2,048,647 |
| SCHOLAR ROCK HLDG CORP | 80706P103 | $84.84B | 1,962,953 |
| ENLIVEN THERAPEUTICS INC | 29337E102 | $72.06B | 3,202,798 |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | $66.06B | 3,445,813 |
| ORUKA THERAPEUTICS INC | 687604108 | $65.38B | 3,371,922 |
| DIANTHUS THERAPEUTICS INC | 252828108 | $58.88B | 2,700,691 |
| COGENT BIOSCIENCES INC | 19240Q201 | $48.56B | 6,225,641 |
| KINIKSA PHARMACEUTICALS INTL | G52694109 | $43.40B | 2,194,341 |
| DAY ONE BIOPHARMACEUTICALS INC | 23954D109 | $39.32B | 3,103,448 |
| ASTRIA THERAPEUTICS INC | 04635X102 | $31.77B | 3,554,129 |
| ANAPTYSBIO INC | 032724106 | $24.05B | 1,816,466 |
| BICARA THERAPEUTICS INC | 055477103 | $22.37B | 1,284,169 |
| INHIBIKASE THERAPEUTICS INC | 45719W205 | $19.91B | 6,125,000 |
| ZENAS BIOPHARMA INC | 98937L105 | $15.50B | 1,892,806 |